|
Market Cap (18-May) $1,025,901,888 (311th) |
Close (30-Jun) $1.55 |
Volume (30-Jun) 1,225,647 |
Shortsold (5-May) 71,471,994 (10.35%) (8th) |
|
52w High $2.78 |
52w Low $0.93 |
P/E 70.92 |
EPS 0.01 |
PNV released this announcement to the ASX on 28 October 2020, 9:11. The announcement is marked as price sensitive, and is 1 page(s) in length and 165.71kb in size.
You can view all announcements from PNV and see how they appear on a price chart on the announcements page.
At the date of this announcement, PNV was 6.145% short sold according to ASIC data. It was ranked the 17th most shorted stock on the ASX. It is now ranked as the 8th most shorted stock on the ASX with 10.346% of total shares short sold as of the latest reported data (05 May 2025).
| Other Recent Announcements from PNV | |
|---|---|
| Appendix 3Y - Robyn Elliott | 30 June 2023, 10:41 |
| Director Share Purchase - David Williams | 8 June 2023, 15:14 |
| Director Share Purchase - David Williams | 8 June 2023, 8:19 |
| First ever A$7M Sales Month | 7 June 2023, 9:12 |
| Trading Halt | 6 June 2023, 12:24 |
| Pause in Trading | 6 June 2023, 12:17 |
| Taiwan FDA Approval for PolyNovo | 28 October 2020, 9:11 |
| There has been no announcements made to the ASX since this one. |
You must be logged in to post a reply.
PolyNovo 